High-Assay Low-Enriched Uranium (HALEU) Stocks
Advanced nuclear fuel cycle participants focus on the production, enrichment, and utilization of uranium enriched between 5% and 20% to support next-generation small modular reactors. These entities address a critical supply chain bottleneck by developing proprietary enrichment technologies and securing feedstock to reduce global reliance on state-controlled fuel sources.
As of Oct 23, 2026, High-Assay Low-Enriched Uranium (HALEU) has 6 US-listed companies worth $10.7B combined. The median member moved -5.7% over the past week; STDN led at +0.4% and LEU trailed at -10.9%.
Companies in High-Assay Low-Enriched Uranium (HALEU)
- OKLO – Oklo Inc., $4.9B
- LEU – Centrus Energy Corp., $2.6B
- STDN – Standard Nuclear, Inc., $2B
- NNE – Nano Nuclear Energy Inc. Common Stock, $699M
- ASPI – ASP Isotopes Inc. Common Stock, $315M
- LTBR – Lightbridge Corp, $191M